Articles related to Residency

A systematic review identified 204 eligible publications from 2000 through 2017, with much of the evidence consisting of systematic reviews of observational data, consensus guidelines, case series, and case reports. Due to the paucity of high-quality evidence on management of immune-related adverse events, recommendations are based on expert consensus.

From the American Red Cross to volunteering overseas, there are plenty of feel-good “enlistments” out there for the practicing or retired physician, which can help ward off boredom and burnout while adding the benefit of perhaps learning a new skill or meeting new people. Whether your goals are short-term or you’re in for the long haul, here are nine opportunities to help humanity and feel good about the part you’re playing in the world.

The plaintiff, an emergency medicine physician, filed the lawsuit for wrongful termination against EmCare’s Kansas and Missouri subsidiaries, alleging that he was terminated because he complained about dangerous and illegal understaffing at the Overland Park emergency department. On March 2, 2021, the Missouri Supreme Court declined to intervene in the case, finalizing the judgment in the plaintiff’s favor.

That’s the question in this highly unusual case, in which the plaintiff made an emergency motion for a mistrial, arguing that the jury witnessing the defendant coming to the aid of one of their fellow jurors may have prejudiced the jury. Read this fascinating story from MPR and ask yourself whether the situation had influenced the verdict in any way or resulted in a denial of a fair trial.

Amy Watson became famous for coining the term “COVID long hauler” to describe people, such as herself, who suffer from the effects of the respiratory disease over an extended period. These long-haul symptoms can include fever, body aches, and fatigue. Watson herself says she rarely goes more than a few hours without suffering a fever, nearly two years after first contracting COVID-19. GoodRx Health chronicles Amy Watson’s story and what it’s like for people suffering from long COVID.

At the outset of the pandemic, biotechnology company Novavax was one of the frontrunners to bring a vaccine against COVID-19 to market. But nearly two years later, Novavax’s vaccine has yet to appear. In a compelling article, the BMJ details the repeated delays and setbacks that have torpedoed Novavax’s once-promising vaccine candidate and rendered it unnecessary now that other vaccines from Pfizer, Moderna, and AstraZeneca flood the global marketplace.